🔎 Trials Near Me

Beranda › Penyakit Graft-versus-Host › Massachusetts

Uji klinis Penyakit Graft-versus-Host di Massachusetts

10 studi untuk Penyakit Graft-versus-Host mencari peserta di lokasi di Massachusetts.

Kota di Massachusetts

Teks studi resmi (Bahasa Inggris)

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

  • Massachusetts General Hospital, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06910969

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

  • Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 1
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT06991361

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  • Massachusetts General Hospital, Boston
Menerima pesertaFase 2
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 16 Jun 2026 · NCT04710576

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT06615050

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

  • Boston Children's Hospital, Boston
Menerima pesertaFase 2
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT04380740

Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial

  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Mar 2026 · NCT05236062

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT06619561

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

  • Dana Farber, Boston
Menerima pesertaStudi observasional
36 Months · Semua jenis kelamin · Diperbarui 20 Okt 2025 · NCT05866302

IS-free Treg HaploHCT

  • Dana Farber Cancer Institute, Boston
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 20 Okt 2025 · NCT04678401

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2025 · NCT06462365

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.